International guidelines for medical journals are too lax and enable drug companies to conceal their contributions to scientific papers, says a personal view published in PLoS Medicine…
http://feeds.bmj.com/~r/bmj/recent/~3/-wFpmLG-yO0/bmj.d5132.short
